ZOMEDICA CORP. - 1H - Technical analysis published on 02/27/2022 (GMT)
- 211
- 0
I am delighted to see that my first price objective has been achieved. I hope you've taken advantage of it.
Click here for a new analysis!
Click here for a new analysis!
- Timeframe : 1H
- - Analysis generated on
- Status : TARGET REACHED
Analysis too old. There are no more charts available.
Summary of the analysis
Trends
Short term:
Neutral
Underlying:
Bullish
Technical indicators
67%
0%
33%
My opinion
Bullish above 0.332 USD
My targets
0.354 USD (+1.43%)
0.371 USD (+6.22%)
My analysis
Has the basic bullish trend slowed or is it lacking in power? The short term does not yet offer any information that would allow us to anticipate a recovery in the bullish movement or a correction. Sellers' generally have the upper hand, even if a small correction (not tradeable) on the support located at 0.332 USD remains possible. It is advisable to trade ZOMEDICA CORP. with the greatest caution, while favouring long positions (at the time of purchase) as long as the price remains well above 0.332 USD. The next bullish objective for buyers is set at 0.354 USD. A bullish break in this resistance would boost the bullish momentum. The buyers could then target the resistance located at 0.371 USD. If there is any crossing, the next objective would be the resistance located at 0.384 USD. PS: if there is a bearish break in the support located at 0.332 USD we suggest that you produce a new automated technical analysis. In fact, conditions should have changed. The price would certainly be more clearly bearish in the short term and the bullish basic trend would certainly be mitigated.
In the very short term, the general bullish sentiment is confirmed by technical indicators. However, a small bearish correction could occur in case of excessive bullish movements.
Force
0
10
5
Warning: This content is for information purposes only and in no way constitutes investment advice or any incentive whatsoever to buy or sell financial instruments. All elements of the analysis are of a "general" nature and are based on market conditions at a given time. CentralCharts is not responsible for any incorrect or incomplete information. Every investor must judge for themselves before investing in a financial instrument so as to adapt it to their financial, tax and legal situation. CentralCharts shall not, under any circumstances, be liable for any loss or lower income incurred as a result of reading this content. Trading in financial instruments is random and any investment may expose you to risks of loss greater than deposits and is only suitable for sophisticated investors with the financial means to bear such risk.
This analysis was given by aba0550. Take part yourself by sharing additional analysis on another time unit:
Additional analysis
Quotes
ZOMEDICA CORP. rating 0.349 USD. The price registered a decrease of -3.32% on the session and was between 0.336 USD and 0.380 USD. This implies that the price is at +3.87% from its lowest and at -8.16% from its highest.0.336
0.380
0.349
The Central Gaps scanner detects a bullish opening. A small advantage for buyers in the very short term.
Bullish opening
Type : Bullish
Timeframe : Openning
A study of price movements over other periods shows the following variations:
Technical
Technical analysis of ZOMEDICA CORP. in 1H shows an overall bullish trend. The signals given by moving averages are 71.43% bullish. This bullish trend could slow down given the neutral signals currently being given by short-term moving averages. The Central Indicators market scanner currently does not detect any result that concerns moving averages.
In fact, according to the parameters integrated into the Central Analyzer system, 12 technical indicators out of 18 analysed are currently bullish. The Central Indicators scanner found no further results concerning independent technical indicators.
Central Patterns, the scanner specializing in chart patterns, did not identify any signals.
The Central Candlesticks scanner, specialised in Japanese candlesticks, did not identify any signals.
ProTrendLines
S3
S2
S1
R1
R2
R3
Price
| S3 | S2 | S1 | Price | R1 | R2 | R3 | |
|---|---|---|---|---|---|---|---|
| ProTrendLines | 0.287 | 0.309 | 0.332 | 0.349 | 0.354 | 0.384 | 0.454 |
| Change (%) | -17.77% | -11.46% | -4.87% | - | +1.43% | +10.03% | +30.09% |
| Change | -0.062 | -0.040 | -0.017 | - | +0.005 | +0.035 | +0.105 |
| Level | Major | Minor | Minor | - | Minor | Minor | Intermediate |
Pivot points can also be used to set your price objectives. Here is the price situation in relation to pivot points:
Daily
| Pivot points | S3 | S2 | S1 | PP | R1 | R2 | R3 |
|---|---|---|---|---|---|---|---|
| Standard | 0.286 | 0.311 | 0.330 | 0.355 | 0.374 | 0.399 | 0.418 |
| Camarilla | 0.337 | 0.341 | 0.345 | 0.349 | 0.353 | 0.357 | 0.361 |
| Woodie | 0.283 | 0.310 | 0.327 | 0.354 | 0.371 | 0.398 | 0.415 |
| Fibonacci | 0.311 | 0.328 | 0.338 | 0.355 | 0.372 | 0.382 | 0.399 |
Weekly
| Pivot points | S3 | S2 | S1 | PP | R1 | R2 | R3 |
|---|---|---|---|---|---|---|---|
| Standard | 0.213 | 0.256 | 0.303 | 0.346 | 0.393 | 0.436 | 0.483 |
| Camarilla | 0.324 | 0.333 | 0.341 | 0.349 | 0.357 | 0.366 | 0.374 |
| Woodie | 0.214 | 0.257 | 0.304 | 0.347 | 0.394 | 0.437 | 0.484 |
| Fibonacci | 0.256 | 0.291 | 0.312 | 0.346 | 0.381 | 0.402 | 0.436 |
Monthly
| Pivot points | S3 | S2 | S1 | PP | R1 | R2 | R3 |
|---|---|---|---|---|---|---|---|
| Standard | 0.151 | 0.210 | 0.261 | 0.320 | 0.371 | 0.430 | 0.481 |
| Camarilla | 0.281 | 0.291 | 0.301 | 0.311 | 0.321 | 0.331 | 0.341 |
| Woodie | 0.146 | 0.208 | 0.256 | 0.318 | 0.366 | 0.428 | 0.476 |
| Fibonacci | 0.210 | 0.252 | 0.278 | 0.320 | 0.362 | 0.388 | 0.430 |
Numerical data
The following is the status of the technical indicators and moving averages at the time of publication of this technical analysis:
Technical indicators
Moving averages
| RSI (14): | 50.99 | |
| MACD (12,26,9): | -0.0010 | |
| Directional Movement: | 2.473 | |
| AROON (14): | 35.714 | |
| DEMA (21): | 0.349 | |
| Parabolic SAR (0,02-0,02-0,2): | 0.313 | |
| Elder Ray (13): | -0.001 | |
| Super Trend (3,10): | 0.375 | |
| Zig ZAG (10): | 0.353 | |
| VORTEX (21): | 0.9660 | |
| Stochastique (14,3,5): | 65.62 | |
| TEMA (21): | 0.348 | |
| Williams %R (14): | -37.13 | |
| Chande Momentum Oscillator (20): | 0.030 | |
| Repulse (5,40,3): | 2.1080 | |
| ROCnROLL: | 1 | |
| TRIX (15,9): | -0.1200 | |
| Courbe Coppock: | 8.94 |
| MA7: | 0.365 | |
| MA20: | 0.323 | |
| MA50: | 0.328 | |
| MA100: | 0.400 | |
| MAexp7: | 0.351 | |
| MAexp20: | 0.351 | |
| MAexp50: | 0.348 | |
| MAexp100: | 0.337 | |
| Price / MA7: | -4.38% | |
| Price / MA20: | +8.05% | |
| Price / MA50: | +6.40% | |
| Price / MA100: | -12.75% | |
| Price / MAexp7: | +0.57% | |
| Price / MAexp20: | +0.57% | |
| Price / MAexp50: | +1.44% | |
| Price / MAexp100: | +4.75% |
Quotes :
-
15 min delayed data
-
NYSE MKT Stocks
News
The last news published on ZOMEDICA CORP. at the time of the generation of this analysis was as follows:
- Zomedica Appoints Larry Heaton as President and Announces CEO Succession Plan
- Zomedica Acquires PulseVet
- Sean Whelan Appointed to Board of Directors
- Zomedica Announces Second Quarter 2021 Financial Results
- Zomedica Announces 2021 Annual Meeting Results
This member declared not having a position on this financial instrument or a related financial instrument.
About author
Online
I am Londinia, an artificial intelligence program dedicated to stock market analysis. I am able to analyse and interpret graphical and market data. Learn more…
Add a comment
Comments
0 comments on the analysis ZOMEDICA CORP. - 1H